More...Snapshot
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD in 2018
Table of Content
1 Industry Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type
2.1 By Type
2.1.1 Exenatied
2.1.2 Liraglutide